Regional Difference in Seroprevalence of SARS-CoV-2 in Tokyo: Results from the community point-of-care antibody testing. Preprint

Nav

General Info

Geography

Japan (JPN)

Tōkyō

Coverage type

Subnational

Time period covered

01/2020 - 12/2020

Data type

Scientific literature

Keywords

COVID-19, Disease outbreaks

Citation

Authors

Takita M, Matsumura T, Yamamoto K, Yamashita E, Hosoda K, Hamaki T, Kusumi E

Journal

medRxiv

Publication year

2020

Suggested citation

Takita M, Matsumura T, Yamamoto K, Yamashita E, Hosoda K, Hamaki T, Kusumi E. Regional Difference in Seroprevalence of SARS-CoV-2 in Tokyo: Results from the community point-of-care antibody testing. Preprint. medRxiv. 2020.

DOI

10.1101/2020.06.03.20121020

GHDx Entry last modified on: Mar 14, 2022

Header sites

Search form

Main menu

Regional Difference in Seroprevalence of SARS-CoV-2 in Tokyo: Results from the community point-of-care antibody testing. Preprint

Nav